Drugs

Lipid Mediators in Inflammatory Disorders
pp. 487-496(10)
Authors: Heller A.; Koch T.; Schmeck J.; van Ackern K.

Antiendotoxin Strategies for the Prevention and Treatment of Septic Shock: New Approaches and Future Directions
pp. 497-508(12)
Authors: Opal S.M.; Yu R.L.J.

The Classification of Calcium Antagonists and their Selection in the Treatment of Hypertension: A Reappraisal
pp. 509-517(9)
Authors: Lüscher T.F.; Cosentino F.

A Practical Guide to the Management of Distal Ulcerative Colitis
pp. 519-542(24)
Authors: Ardizzone S.; Porro G.B.

Hyperthyroidism: Current Treatment Guidelines
pp. 543-553(11)
Authors: Gittoes N.J.L.; Franklyn J.A.

Recognition and Treatment of Idiopathic Pulmonary Fibrosis
pp. 555-562(8)
Author: Nicod L.P.

Glimepiride: A Review of its Use in the Management of Type 2 Diabetes Mellitus
pp. 563-584(22)
Authors: Langtry H.D.; Balfour J.A.

Liposomal Amphotericin B: Therapeutic Use in the Management of Fungal Infections and Visceral Leishmaniasis
pp. 585-612(28)
Authors: Coukell A.J.; Brogden R.N.